Your Complete Solution for Investigating Autoimmune Neuropathies

The IVDR-compliant BÜHLMANN GanglioCombi® MAG ELISA sets a new standard for investigating autoimmune-related peripheral neuropathies by combining MAG and ganglioside antigens in a unique multiparametric IVD ELISA. This innovative kit includes a comprehensive antigen profile: «MAG», GM1, GT1a, GD1a, GD1b, and GQ1b.

Neurologists and laboratories benefit from its efficient, cost-effective, and streamlined workflow, enabling targeted screening for prominent immune-mediated neuropathies in just two easy steps. The kit comes complete with all enzyme label-conjugates, ensuring a thorough and economical work-up.

Test results are categorized as negative, positive, or equivocal, aligning with the nuanced interpretation required in autoimmunology. A positive MAG (IgM) result can suggest MAG neuropathy or MGUS (monoclonal gammopathy of unknown significance) and may be further confirmed with the gold-standard anti-MAG Antibodies ELISA, providing confidence and clarity for clinical decision-making.


BÜHLMANN GanglioCombi® MAG ELISA Product Information

Method ELISA
Analytes anti-MAG* and –Ganglioside antibodies (GM1, GT1a, GD1a, GD1b, GQ1b)
Time to Result 4.5 h (approx.)
Sample type and -volume serum; 100 uL (1:50)
Enzyme-labels IgG/IgM Mix, IgM and IgG
Results % Ratio of Calibrator
Cut-off 50%
Order Code EK-GCM
CE (IVDR compliant)

* Chemically synthesized HNK-1 epitope of the MAG glycoprotein

Downloads